Replimune (REPL) Return on Equity [ROE] (2018 - 2026)
Replimune (REPL) reported Return on Equity [ROE] of -173.89% for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 70.64 percentage points from -103.25% a year earlier but up 43.22 percentage points from the prior quarter.
Powered by 
Analysis
Replimune (REPL) Return on Equity [ROE] (2018 - 2026) Analysis & Trends
For FY2026 (ended Mar 31, 2026), Replimune posted Return on Equity [ROE] of -108.07%, down 45.61 percentage points from FY2025.
- Return on Equity [ROE] has declined for five consecutive fiscal years, with a five-year change of -84.67 percentage points (FY2021 to FY2026).
- By fiscal year, Return on Equity [ROE] came in at -62.46% in FY2025 (-16.13 pp), -46.33% in FY2024 (-10.32 pp), -36.00% in FY2023 (-10.06 pp) and -25.94% in FY2022 (-2.54 pp).
- Five-year quarterly Return on Equity [ROE] spans a low of -217.10% in fiscal Q1 2027 and a high of -24.17% in fiscal Q3 2022.
- Year over year, Return on Equity [ROE] has now declined in each of the last 20 quarters, with an average year-over-year change of -60.10 percentage points over the last eight quarters.
- The year-over-year drop in Return on Equity [ROE] has ranged between 0.85 percentage points (fiscal Q4 2025) and 142.49 percentage points (fiscal Q1 2027) over the last five years.
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at -217.10% (Q1 2027), -166.37% (Q4 2026) and -132.66% (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | - |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 29.03% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 17.57% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 4.66% |
| 10 | Replimune | 2.40 Bn | 1.35 Bn | - | -173.89% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -173.89% |
| Jun 30, 2026 | -217.10% |
| Mar 31, 2026 | -166.37% |
| Dec 31, 2025 | -132.66% |
| Sep 30, 2025 | -103.25% |
| Jun 30, 2025 | -74.61% |
| Mar 31, 2025 | -55.07% |
| Dec 31, 2024 | -52.84% |
| Sep 30, 2024 | -52.73% |
| Jun 30, 2024 | -54.94% |
| Mar 31, 2024 | -54.22% |
| Dec 31, 2023 | -47.37% |
| Sep 30, 2023 | -40.55% |
| Jun 30, 2023 | -33.97% |
| Mar 31, 2023 | -30.30% |
| Dec 31, 2022 | -32.04% |
| Sep 30, 2022 | -36.97% |
| Jun 30, 2022 | -32.35% |
| Mar 31, 2022 | -27.79% |
| Dec 31, 2021 | -24.17% |
API Access
Replimune Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();